NKCx Histopathological outcome* within 12 months after cervix cytology in 2021
501 Sahlgrenska

  Benign LSIL HSIL AIS Cancer Other PAD missing Total
Cytologi Antal Andel Antal Andel Antal Andel Antal Andel Antal Andel Antal Andel Antal Andel Antal Andel
Benign sample 1595 5.3% 633 2.1% 76 0.3% 11 0.0% 4 0.0% 15 0.0% 27916 92.3% 30250 100.0%
ASCUS 1328 28.8% 1250 27.1% 390 8.4% 5 0.1% 5 0.1% 21 0.5% 1618 35.0% 4617 100.0%
LSIL 251 23.3% 434 40.4% 170 15.8% . . 2 0.2% 10 0.9% 208 19.3% 1075 100.0%
Atypical glandular cells/AGC 3 10.3% 5 17.2% 2 6.9% 6 20.7% 7 24.1% 2 6.9% 4 13.8% 29 100.0%
Unclear atypia 3 50.0% 2 33.3% . . . . . . 1 16.7% . . 6 100.0%
ASC-H 18 8.3% 63 29.0% 120 55.3% 4 1.8% 5 2.3% 3 1.4% 4 1.8% 217 100.0%
HSIL 16 4.4% 37 10.1% 283 77.5% 4 1.1% 16 4.4% 1 0.3% 8 2.2% 365 100.0%
Suspected Adenocarcinom 1 7.7% 1 7.7% . . 2 15.4% 6 46.2% . . 3 23.1% 13 100.0%
Squamous cell cancer . . . . . . . . 2 50.0% . . 2 50.0% 4 100.0%
Totalt 3215 8.8% 2425 6.6% 1041 2.8% 32 0.1% 47 0.1% 53 0.1% 29763 81.4% 36576 100.0%

NOTE: Histopathological outcome from T83x taken into account.
This list includes only one diagnosis (the highest ranking) per person, applies to both Cyt and Pad.

* Harmonization of PAD codes classification between analysis registry and process registry has been carried out. PAD Class 0 (non diagnostic, unreasonable diagnosis) is excluded, and next PAD counts instead.
The classes 2a, b, c and 3a (suspected premalignant, pre-malignant UNS, HPV, suspected malignant) are grouped into 'Other'.
Process Registry's Class 1 (benign), 2d (LSIL) and 3b (manifest cancer) have all been introduced without exception. Some codes that occur beyond the scope of the process registry has been added to the different categories.
 

Snomed codes in the category Cancer:
M80413, M80703, M80706, M81403, M84616